नवीनतम
Health ministry welcomes move to exempt 3 cancer drugs from customs duty
NEW DELHI [Maha Media]: The custom duty exemption proposed for three cancer medicines in the Union Budget will improve the affordability of the drugs, the Union Health Ministry said on Wednesday.
The request for custom duty exemption for Trastuzumab deruxtecan (for breast cancer or gastroesophageal adenocarcinoma), Osimertinib (drug for lung cancers with specific mutation), and Durvalumab (for lung and biliary tract cancers) was forwarded by the Health ministry to the Ministry of Finance keeping in view 27 lakh cancer patients in the country.
The government proposes to cut customs duties on the three drugs from 10 per cent to nil.
